Australia and New Zealand vs South Africa: Percentage of bloodstream infection due to methicillin-resistant
Australia and New Zealand
15.0%
in 2022
South Africa
16.5%
in 2022
Australia and New Zealand rank
30th
South Africa rank
29th
Percentage of bloodstream infection due to methicillin-resistant over time
- Australia and New Zealand
- South Africa
How they compare
South Africa currently reports 16.5% against 15.0% in Australia and New Zealand, a difference of 1.5%.
That makes South Africa's figure about 1.1 times Australia and New Zealand's.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Australia and New Zealand ahead.
Australia and New Zealand ranks 30th and South Africa ranks 29th of 50 countries.
Across the 2 decades both report, Australia and New Zealand averaged higher in 1 and South Africa in 1.
Head to head by decade
| Decade | Australia and New Zealand | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.6% | 23.0% | 0.6% | Australia and New Zealand |
| 2020s | 16.5% | 17.6% | 1.1% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Australia and New Zealand or South Africa?
- South Africa, at 16.5% against 15.0% in Australia and New Zealand as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Australia and New Zealand and South Africa?
- 1.5%, with South Africa ahead.
- How many years of comparable data are there for Australia and New Zealand and South Africa?
- 5 years are reported by both, from 2018 to 2022.
- How do Australia and New Zealand and South Africa rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Australia and New Zealand ranks 30th and South Africa ranks 29th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.